Trevor Cardinal

Title: Trevor Cardinal: Innovator in Arteriogenesis Enhancement

Introduction

Trevor Cardinal is a notable inventor based in San Luis Obispo, CA (US). He has made significant contributions to the field of medical science, particularly in enhancing arteriogenesis. His innovative approach addresses critical health issues related to ischemic diseases.

Latest Patents

Trevor Cardinal holds a patent for "Methods and compositions to enhance arteriogenesis." This patent describes a method for enhancing arteriogenesis in animals with comorbidities commonly found in patients suffering from ischemic disease. The method involves the administration of satellite-derived myoblasts, which increases the maximum diameter of collateral arteries. This is particularly effective in obese animals or those with genetically-impaired arteriogenesis responses. The administration of these myoblasts does not yield the same results in non-obese animals. The patent highlights the potential for increased blood flow and decreased ischemia, along with compositions and kits that include the myoblasts.

Career Highlights

Trevor is associated with Cal Poly Corporation, where he continues to work on innovative solutions in the medical field. His research and development efforts have positioned him as a key figure in advancing treatments for ischemic conditions.

Collaborations

Trevor collaborates with talented individuals such as Vahid Hamzeinejad and Ethan Tietze, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Trevor Cardinal's work in enhancing arteriogenesis represents a significant advancement in medical science. His innovative methods and compositions have the potential to improve the quality of life for patients with ischemic diseases.